What changed in this filing

/stocks — the workspaceLOADING

Item 1A. Risk Factors

2025-11-14 compared with 2025-08-14 · 18 added, 25 removed, 31 unchanged (58% of the section changed)

19 unchanged sentences

Rule 5550(a)(2), and we were not in compliance with the minimum $2,500,000 stockholders’ equity requirement for continued listing

set forth in Listing Rule 5550(b) (the “Equity Requirement”).

As of the date of this filing, we are in compliance with both

requirements.

With respect to the Equity Requirement, pursuant

to Nasdaq Listing Rule 5815(d)(4)(B), we are subject to a Mandatory Panel Monitor until September 10, 2025.

If, within that monitoring

period, the Staff finds us again out of compliance with the Equity Requirement, notwithstanding Listing Rule 5810(c)(2), we will not

be permitted to provide the Staff with a plan of compliance with respect to that deficiency and Staff will not be permitted to grant

additional time for us to regain compliance with respect to that deficiency, nor will we be afforded an applicable cure or compliance

period pursuant to Listing Rule 5810(c)(3).

set forth in Listing Rule 5550(b) .

As of the date of this filing, we are in compliance with both requirements.

With respect to the Minimum Bid Price Requirement,

1 unchanged sentence

If, within that monitoring

period, the Staff finds us again out of compliance with the Equity Requirement, notwithstanding Listing Rule 5810(c)(2), we will not be

permitted to provide the Staff with a plan of compliance with respect to that deficiency and Staff will not be permitted to grant additional

time for us to regain compliance with respect to that deficiency, nor will we be afforded an applicable cure or compliance period pursuant

to Listing Rule 5810(c)(3).

In addition, with respect to the Minimum Bid Price Requirement, since we completed a reverse split on July

22, 2025, if we fall out of compliance with the Minimum Bid Price Requirement prior to July 22, 2026, we will not be eligible for any

compliance period specified in Listing Rule 5810(c)(3)(A).

In either case described in the preceding two sentences, the Staff will issue

a Delist Determination Letter and we will have an opportunity to request a hearing.

Our common stock may be at that time be delisted from

period, the Staff finds us again out of compliance with the Minimum Bid Requirement, notwithstanding Listing Rule 5810(c)(2), we will

not be permitted to provide the Staff with a plan of compliance with respect to that deficiency and Staff will not be permitted to grant

additional time for us to regain compliance with respect to that deficiency, nor will we be afforded an applicable cure or compliance

period pursuant to Listing Rule 5810(c)(3).

In addition, with respect to the Minimum Bid Price Requirement, since we completed a reverse

split on July 22, 2025, if we fall out of compliance with the Minimum Bid Price Requirement prior to July 22, 2026, we will not be eligible

for any compliance period specified in Listing Rule 5810(c)(3)(A).

In either case described in the preceding two sentences, the Staff

will issue a Delist Determination Letter and we will have an opportunity to request a hearing.

Our common stock may be at that time be

delisted from Nasdaq.

There can be no assurance that we will continue

1 unchanged sentence

from The Nasdaq Capital Market would adversely affect our ability to raise additional financing through the public or private sale of

equity securities, may significantly affect the ability of investors to trade our securities and may negatively affect the value and

liquidity of our common stock.

Delisting also could have other negative results, including the potential loss of employee confidence,

the loss of institutional investors or interest in business development opportunities.

equity securities, may significantly affect the ability of investors to trade our securities and may negatively affect the value and liquidity

of our common stock.

Delisting also could have other negative results, including the potential loss of employee confidence, the loss of

institutional investors or interest in business development opportunities.

Unregistered Sales of Equity Securities and Use of Proceeds

We have not issued any unregistered securities

during the quarter ended June 30, 2025.

during the quarter ended September 30, 2025.

Defaults Upon Senior Securities

2 unchanged sentences

Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.

What changed 10-Q

Item 1A. Risk Factors